27 November 2020
The Epilepsy12 Youth Advocates have been selected as joint winners in the HQIP Audit Heroes Awards 2020 in the Volunteer of the Year Category, recognising their hard work to support improvements in epilepsy care.
20 October 2020
As part of our Shape of training programme, we asked thousands of children and young people what knowledge, skills and attitude the paediatrician of the future needs. The top themes? Being respectful, kind and friendly, being listened to and understood, having good communication focused on age and n...
2 October 2020
An interim clinical commissioning policy has been in place across the UK since 3 July 2020, defining routine access to remdesivir in the treatment of COVID-19 in adults and children aged 12 years or older. However, due to increased demand against available supply, clinicians are now asked to apply t...
9 September 2020
Following recent publication of the REMAP-CAP trial for hydrocortisone and a meta-analysis of corticosteroids, the World Health Organization (WHO) has recently issued new interim guidance recommending the use of systemic corticosteroids in severe and critical COVID-19 disease.
26 June 2020
Ranitidine products (Brand names including Zantac®) were voluntarily withdrawn by manufacturers in October 2019, because of fears that they may contain low levels of an impurity called NMDA.
17 March 2020
The RCPCH/NPPG Medicines Committee has recently been informed of a severe adverse reaction in a six-month old child with anisocoria who had been administered apraclonidine 1% to help exclude Horner syndrome.
10 March 2020
A few years ago, I got the chance to speak with young carers about their experiences. Together, we created superhero characters to explain some of the many things that they do—and some other things they would like to do. As the RCPCH’s children and young people’s engagement manager, I get to meet wi...
7 March 2020
A good start in life is critical for health—and this story begins before birth. The WHO states that monitoring maternal and child health during pregnancy is critical, and that smoking is one of the most important modifiable lifestyle choices during this period.
2 March 2020
The Medicines and Healthcare products Regulatory Agency (MHRA) is requesting that healthcare professionals report any suspected side effects or safety concerns with e-cigarettes and the e-liquids used for vaping to the Yellow Card Scheme.
5 February 2020
Dr Mike Linney, Registrar and Chair of the Ethics Committee for RCPCH, welcomes recent guidance from NICE, but notes the urgent need for high quality, independent research on this medicine to provide the best possible care for children with complex epilepsy.